AVXL Stock Price
Anavex Life Sciences Corp.
AVXL stock price is $1.15 (+3.60% on the day), giving Anavex Life Sciences Corp. a market cap of $106.60M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
AVXL Stock Overview
- Price
- $1.15
- Previous close
- $1.11
- Open
- $1.12
- Market cap
- $106.60M
- 52-week range
- $1.06 - $7.60
- 1-year price target
- $20.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- Nasdaq
- MarketXLS Rank
- 30
About Anavex Life Sciences Corp.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States. The company's lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. Anavex Life Sciences Corp. was incorporated in 2001 and is headquartered in New York, New York.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVXL | $1.15 | +3.6% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Anavex Life Sciences Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW